BPC-157
RegenesisMD advertises BPC-157 within supervised recovery-oriented protocols and labels its peptide therapies investigational or off-label.
Provider source ↗
Raleigh, NC · Telehealth available
Provider overview
RegenesisMD publishes a North Raleigh clinic address and identifies Bhavna Vaidya, MD, as founder and medical director. Its official peptide page explicitly describes peptide therapies as compounded, investigational and/or off-label, and not FDA-approved for the promoted indications. Telehealth is limited on the reviewed source to follow-up for established patients in North Carolina.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
RegenesisMD advertises BPC-157 within supervised recovery-oriented protocols and labels its peptide therapies investigational or off-label.
Provider source ↗TB-500 is named in the clinic's public peptide catalog; inclusion does not establish approval, safety, or effectiveness.
Provider source ↗Sermorelin is listed in a provider-supervised growth-hormone optimization pathway.
Provider source ↗The combination is named in the clinic's public peptide materials and remains subject to clinical screening.
Provider source ↗MOTS-C is listed in the clinic's metabolic peptide catalog without implying regulatory approval or expected results.
Provider source ↗The clinic advertises tesamorelin-related blends; approved indications must not be generalized to advertised uses.
Provider source ↗Physician-supervised GLP-1 and GIP/GLP-1 weight-management pathways are listed with ongoing monitoring.
Provider source ↗NAD+ IV therapy is advertised at the Raleigh clinic as part of its wellness catalog.
Provider source ↗BHRT and testosterone optimization are listed as lab-guided services for women and men.
Provider source ↗The clinic advertises advanced lab work and health screening to inform individualized planning.
Provider source ↗Telehealth follow-ups are explicitly described for established patients throughout North Carolina.
Provider source ↗The clinic advertises PRP, joint injections, and stem-cell-related services while noting investigational status for orthopedic stem-cell use.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity location phone medical director and service catalog · Checked Jul 24, 2026
Supports: specific peptides telehealth and regulatory caveats · Checked Jul 24, 2026
Supports: location services and contact · Checked Jul 24, 2026
Supports: hormone services and clinical leadership · Checked Jul 24, 2026
Supports: organization record · Checked Jul 24, 2026